Solenic Medical
College Station, US · Founded 2019 · Delaware corporation · 2 known investors
Develops a non-invasive solution using alternating magnetic field technology to treat infected metallic implants by eradicating biofilms.
Founders & leadership
JY
James Y LancasterExecutive Officer, Director
JH
John HodockDirector
RC
Robert Calvin GoforthDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$3.2MraisedMar 2024 · 17 investors · BiotechnologyRule 506(b)
▶$3.2MraisedMar 2024 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David GreenbergExecutive Officer
- James LancasterExecutive Officer, Director
- Calvin GoforthDirector
- Tamir MeiriDirector
- John HodockDirector
- Rajiv ChopraExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $3.2M
- Minimum investment
- $1
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b, 4a5
▶$2.2MraisedFeb 2024 · 9 investors · BiotechnologyRule 506(b)
▶$2.2MraisedFeb 2024 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James LancasterExecutive Officer, Director
- Rajiv ChopraExecutive Officer, Director
- Calvin GoforthDirector
- Tamir MeiriDirector
- John HodockDirector
- David GreenbergExecutive Officer
- Offering amount
- $4M
- Amount sold
- $2.2M
- Minimum investment
- $1
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b, 4a5
▶$3.7MraisedDec 2022 · 11 investors · Other Health CareRule 506(b)
▶$3.7MraisedDec 2022 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John HodockDirector
- Calvin GoforthDirector
- David GreenbergExecutive Officer
- Mark WagstaffExecutive Officer
- Tamir MeiriDirector
- John TepperDirector
- Rajiv ChopraExecutive Officer, Director
- James Y LancasterExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $3.7M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$75KraisedAug 2022 · 3 investors · OtherRule 506(b)
▶$75KraisedAug 2022 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- John HodockDirector
- James Y. LancasterExecutive Officer, Director
- Robert Calvin GoforthDirector
- Offering amount
- $500K
- Amount sold
- $75K
- Minimum investment
- $5K
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$100KraisedMay 2021 · 2 investors · OtherRule 506(b)
▶$100KraisedMay 2021 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- James Y LancasterExecutive Officer, Director
- John HodockDirector
- Robert Calvin GoforthDirector
- Offering amount
- $1M
- Amount sold
- $100K
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$125KraisedMay 2020 · 3 investors · OtherRule 506(b)
▶$125KraisedMay 2020 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- James Y. LancasterExecutive Officer, Director
- Robert Calvin GoforthDirector
- John HodockDirector
- Offering amount
- $500K
- Amount sold
- $125K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$250KraisedAug 2019 · 1 investors · OtherRule 506(b)
▶$250KraisedAug 2019 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- R. Calvin GoforthDirector
- James Y. LancasterExecutive Officer, Director
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.